In contrast, in human melanoma and murine tumor models, mass cytometry analyses used to comprehensively profile the effects of anti-PD-1 mAbs on TILs reveal an increased CD8+/Treg cell ratio due to an expansion of CD8+PD-1+ T cells, whereas the Tregs population was not significantly modulated [369]. This evidence concerns the gene PDCD1 and melanoma.